DNA prime-protein boost strategy with replicase-based DNA vaccine against foot-and-mouth disease in bovine calves.

No abstract is available for this paper.

• Publication year

  2013

• Venue

  Veterinary Microbiology

• Publication date

  2013-04-12

• Fields of study

  Agricultural and Food Sciences, Medicine, Biology

• Identifiers
  DOI 10.1016/j.vetmic.2012.12.017PMID 23305616
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• E. coli expressed proteins as diagnostic reagents for typing of foot-and-mouth disease virus

  2014cited by this paper
• Sindbis Virus Replicase‐based DNA Vaccine Construct Encoding FMDV‐specific Multivalent Epitope Gene: Studies on its Immune Responses in Guinea Pigs

  2012cited by this paper
• Foot-and-mouth disease virus epitope dominance in the antibody response of vaccinated animals.

  2012cited by this paper
• Interferon-γ Induced by In Vitro Re-Stimulation of CD4+ T-Cells Correlates with In Vivo FMD Vaccine Induced Protection of Cattle against Disease and Persistent Infection

  2012cited by this paper
• Development of vaccines toward the global control and eradication of foot-and-mouth disease

  2011cited by this paper
• Antibody responses elicited through homologous or heterologous prime-boost DNA and protein vaccinations differ in functional activity and avidity.

  2010cited by this paper
• Alphavirus vectors for cancer therapy.

  2010cited by this paper
• High interleukin-12 production from stimulated peripheral blood mononuclear cells of type 2 diabetes patients.

  2010cited by this paper
• Comparison of single, homologous prime-boost and heterologous prime-boost immunization strategies against H5N1 influenza virus in a mouse challenge model.

  2010cited by this paper
• Foot and mouth disease virus vaccines.

  2009cited by this paper
• Foot-and-Mouth Disease Virus neutralizing antibodies production induced by pcDNA3 and Sindbis virus based plasmid encoding FMDV P1-2A3C3D in swine.

  2009cited by this paper
• BoLA-DR peptide binding pockets are fundamental for foot-and-mouth disease virus vaccine design in cattle.

  2009cited by this paper
• Indirect foot-and-mouth disease vaccine potency testing based on a serological alternative.

  2008cited by this paper
• Cloning and expression of FMDV-VP1 immunoreactive peptide in trivalent form and its application as immunogen

  2008cited by this paper
• Dramatic improvement in FMD DNA vaccine efficacy and cross-serotype antibody induction in pigs following a protein boost.

  2008cited by this paper
• Poverty impacts of foot-and-mouth disease and the poverty reduction implications of its control

  2007cited by this paper
• Increased Immunogenicity of a DNA-Launched Venezuelan Equine Encephalitis Virus-Based Replicon DNA Vaccine

  2007cited by this paper
• Enhanced immunogenicity to food-and-mouth disease virus in mice vaccination with alphaviral replicon-based DNA vaccine expressing the capsid precursor polypeptide (P1)

  2006cited by this paper
• Effect of emergency FMD vaccine antigen payload on protection, sub-clinical infection and persistence following direct contact challenge of cattle.

  2006cited by this paper
• Interferon-gamma production in vitro from whole blood of foot-and-mouth disease virus (FMDV) vaccinated and infected cattle after incubation with inactivated FMDV.

  2006cited by this paper
• DNA Prime Followed by Protein Boost Enhances Neutralization and Th1 Type Immunity Against FMDV

  2005cited by this paper
• Apoptosis is essential for the increased efficacy of alphaviral replicase-based DNA vaccines.

  2004cited by this paper
• Foot-and-Mouth Disease

  2004cited by this paper
• Evidence that high potency foot-and-mouth disease vaccine inhibits local virus replication and prevents the "carrier" state in sheep.

  2004cited by this paper
• Differential Antigen Presentation Regulates the Changing Patterns of CD8+ T Cell Immunodominance in Primary and Secondary Influenza Virus Infections

  2003cited by this paper
• Enhanced Immunogenicity to Mycobacterium tuberculosis by Vaccination with an Alphavirus Plasmid Replicon Expressing Antigen 85A

  2003cited by this paper
• Evolution of foot-and-mouth disease virus.

  2003cited by this paper
• Alphavirus-based DNA vaccine breaks immunological tolerance by activating innate antiviral pathways

  2003cited by this paper
• The Potential of DNA Vaccination against Tumor-Associated Antigens for Antitumor Therapy

  2002cited by this paper
• Induction of cytotoxic T-lymphocytes specific for bovine herpesvirus-1 by DNA immunization.

  2002cited by this paper
• Enhancement of the immunity to foot-and-mouth disease virus by DNA priming and protein boosting immunization.

  2001cited by this paper
• Recognition of double-stranded RNA and activation of NF-κB by Toll-like receptor 3

  2001cited by this paper
• Vaccines against intracellular infections requiring cellular immunity

  2000cited by this paper
• Enhancement of tumor-specific immune response with plasmid DNA replicon vectors.

  2000cited by this paper
• Plasmids encoding foot-and-mouth disease virus VP1 epitopes elicited immune responses in mice and swine and protected swine against viral infection.

  2000cited by this paper
• CD4+ T Cell Priming Accelerates the Clearance of Sendai Virus in Mice, but Has a Negative Effect on CD8+ T Cell Memory1

  2000cited by this paper
• Primary diagnosis of foot-and-mouth disease by reverse transcription polymerase chain reaction.

  2000cited by this paper
• The prime-boost strategy: exciting prospects for improved vaccination.

  2000cited by this paper
• Comparison of the protective efficacy of naked DNA, DNA-based Sindbis replicon, and packaged Sindbis replicon vectors expressing Hantavirus structural genes in hamsters.

  1999cited by this paper
• Effective induction of HIV-specific CTL by multi-epitope using gene gun in a combined vaccination regime.

  1999cited by this paper
• Cancer therapy using a self-replicating RNA vaccine

  1999cited by this paper
• Development of DNA vaccines for foot-and-mouth disease, evaluation of vaccines encoding replicating and non-replicating nucleic acids in swine.

  1999cited by this paper
• Recombinant Fusion Protein and DNA Vaccines Against Foot and Mouth Disease Virus Infection in Guinea Pig and Swine

  1999cited by this paper
• C-terminal region of VP1 of selected foot-and-mouth disease virus serotypes: expression in E. coli and affinity purification.

  1999cited by this paper
• DNA and RNA-based vaccines: principles, progress and prospects.

  1999cited by this paper
• Enhancing immune responses using suicidal DNA vaccines

  1998cited by this paper
• DNA Immunization against Herpes Simplex Virus: Enhanced Efficacy Using a Sindbis Virus-Based Vector

  1998cited by this paper
• Immature Dendritic Cells Phagocytose Apoptotic Cells via αvβ5 and CD36, and Cross-present Antigens to Cytotoxic T Lymphocytes

  1998cited by this paper
• Antibody Response in Mice Inoculated with DNA Expressing Foot-and-Mouth Disease Virus Capsid Proteins

  1998cited by this paper
• A double-stranded RNA-activated protein kinase-dependent pathway mediating stress-induced apoptosis.

  1997cited by this paper
• A large-scale evaluation of peptide vaccines against foot-and-mouth disease: lack of solid protection in cattle and isolation of escape mutants

  1997cited by this paper
• Plasmid DNA encoding replicating foot-and-mouth disease virus genomes induces antiviral immune responses in swine

  1997cited by this paper
• A Study of the Interferon Antiviral Mechanism: Apoptosis Activation by the 2–5A System

  1997cited by this paper
• Induction of effective cross-reactive immunity by FMDV peptides is critically dependent upon specific MHC-peptide-T cell interactions.

  1994cited by this paper
• Relationship between the anti-FMD virus antibody reaction as measured by different assays, and protection in vivo against challenge infection.

  1992cited by this paper
• A potency test method for foot and mouth disease vaccine based on the serum neutralizing antibody response produced in cattle.

  1992cited by this paper
• Foot-and-mouth disease virus populations are quasispecies.

  1992cited by this paper
• Development of foot-and-mouth disease virus strain characterisation—A review

  1989cited by this paper
• Immunization against foot-and-mouth disease with synthetic peptides representing the C-terminal region of VP1.

  1988cited by this paper
• Sources of variability in foot and mouth disease vaccine potency estimates based on serum neutralizing antibody assay.

  1987cited by this paper
• Protection of cattle against foot-and-mouth disease by a synthetic peptide.

  1986cited by this paper
• Protection against foot-and-mouth disease by immunization with a chemically synthesized peptide predicted from the viral nucleotide sequence

  1982cited by this paper
• Protein measurement with the Folin phenol reagent.

  1951cited by this paper
• A SIMPLE METHOD OF ESTIMATING FIFTY PER CENT ENDPOINTS

  1938cited by this paper

• Foot and Mouth Disease Vaccine Development and Challenges in Inducing Long-Lasting Immunity: Trends and Current Perspectives

  2021influential citation
• Enhanced Protective Immune Response of Foot-and-mouth Disease Vaccine through DNA-loaded Virus-like Particles.

  2020cites this paper
• Protection of chicks from Newcastle disease by combined vaccination with a plasmid DNA and the pre-fusion protein of the virulent genotype VII of Newcastle disease virus.

  2020cites this paper
• Foot-and-mouth disease vaccines: recent updates and future perspectives

  2019cites this paper
• Foot-and-Mouth Disease Virus: Immunobiology, Advances in Vaccines and Vaccination Strategies Addressing Vaccine Failures—An Indian Perspective

  2019cites this paper
• Enhanced humoral and cellular immune responses to PRRS virus GP5 glycoprotein by DNA prime-adenovirus boost vaccination in mice

  2016cites this paper
• Kinetics of cytokine expression in bovine PBMCs and whole blood after in vitro stimulation with foot-and-mouth disease virus (FMDV) antigen.

  2015cites this paper
• Strategies for combating and eradicating important infectious diseases of animals with particular reference to India: present and future perspectives.

  2014cites this paper
• pH-sensitive carbonate apatite nanoparticles as DNA vaccine carriers enhance humoral and cellular immunity.

  2014cites this paper
• Montanide ISA™ 201 adjuvanted FMD vaccine induces improved immune responses and protection in cattle.

  2013cites this paper
• Co-administration of flagellin augments immune responses to inactivated foot-and-mouth disease virus (FMDV) antigen.

  2013cites this paper